HALO Precision Diagnostics Collaborating with Bayer to Advance Contrast-Enhanced MRI
HALO Tapped to Support Bayer’s Phase III Clinical Development Program, QUANTI.
HALO Precision Diagnostics Appoints Thomas P. Slavin, M.D., as Chief Scientific Officer
HALO is bringing on respected clinical leader and scientist as chief scientific officer.
HALO Precision Diagnostics Appoints John Craighead as Chief Operating Officer and Chief Financial Officer
HALO is bringing on life-science industry veteran as chief operating officer and chief financial officer.
Exploring the Intersection of Sports and Medical Genetics
Learn more about Dr. Stuart Kim & Neil deGrasse Tyson’s Startalk conversation on how genetics can impact sports performance.
HALO Provides the Best in Medical Imaging with New AI-Powered CT in the Coachella Valley
HALO is bringing the latest in advanced imaging technology to the Coachella Valley with our new CT 5100 Incisive that utilizes deep-learning AI.
HALO Precision Diagnostics Expands Imaging and Genetic Services to Serve Chico Community
HALO is expanding its imaging and genetic services in the Greater Chico, CA Area after the closure of Open Systems Imaging.
Dr. Feller Shares “The 5 Things Everyone Needs to Know About Cancer”
Dr. John Feller, Chief Medical Officer for HALO, shares “The 5 Things Everyone Needs to Know About Cancer” with Authority Magazine.
Paving the Way Forward: HALO Chico Breast Center Awarded ACR’s Prestigious Breast Imaging Center of Excellence Designation
HALO Breast Care Center is now an ACR-accredited BICOE, providing the highest standards of quality and safety in breast screening.
California Passes Bill AB 632, Helping Men Afford Prostate Screenings
CA Bill 632 will allow more men to receive prostate cancer screenings without the worry of healthcare expenses.
Prostate Cancer Foundation Promotes Early Detection with “Black Men: Know Your Risk” Campaign
The PCF’s recent campaign highlights the disproportionate prostate cancer burden on Black men and the importance of early detection.